These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38745667)

  • 1. Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis.
    Varghese JF; Kaskow BJ; von Glehn F; Case J; Li Z; Julé AM; Berdan E; Ho Sui SJ; Hu Y; Krishnan R; Chitnis T; Kuchroo VK; Weiner HL; Baecher-Allan CM
    Front Immunol; 2024; 15():1360219. PubMed ID: 38745667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.
    Aravena O; Ferrier A; Menon M; Mauri C; Aguillón JC; Soto L; Catalán D
    Arthritis Res Ther; 2017 Jan; 19(1):8. PubMed ID: 28103916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1
    Ye L; Zhang Q; Cheng Y; Chen X; Wang G; Shi M; Zhang T; Cao Y; Pan H; Zhang L; Wang G; Deng Y; Yang Y; Chen G
    J Immunother Cancer; 2018 Dec; 6(1):145. PubMed ID: 30526680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
    Gilbert RM; Zhang X; Sampson RD; Ehrenstein MR; Nguyen DX; Chaudhry M; Mein C; Mahmud N; Galatowicz G; Tomkins-Netzer O; Calder VL; Lightman S
    Front Immunol; 2018; 9():907. PubMed ID: 29774027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and Activity of TIM-1 and IL-10-Reporter Expressing Regulatory B Cells.
    Mohib K; Rothstein DM; Ding Q
    Methods Mol Biol; 2021; 2270():179-202. PubMed ID: 33479899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Deficit of CEACAM-1-Expressing T Lymphocytes Supports Inflammation in Primary Progressive Multiple Sclerosis.
    Piancone F; Saresella M; Marventano I; La Rosa F; Caputo D; Mendozzi L; Rovaris M; Clerici M
    J Immunol; 2019 Jul; 203(1):76-83. PubMed ID: 31142599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic Sclerosis.
    Fleury M; Belkina AC; Proctor EA; Zammitti C; Simms RW; Lauffenburger DA; Snyder-Cappione JE; Lafyatis R; Dooms H
    Arthritis Rheumatol; 2018 Apr; 70(4):566-577. PubMed ID: 29245183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Tim-1 and IL-10 Expression in Regulatory B Cell Subsets in Type 1 Diabetes.
    Liu Y; Chen Z; Qiu J; Chen H; Zhou Z
    Front Immunol; 2021; 12():773896. PubMed ID: 35754999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.
    Piancone F; Saresella M; Marventano I; La Rosa F; Zoppis M; Agostini S; Longhi R; Caputo D; Mendozzi L; Rovaris M; Clerici M
    Sci Rep; 2016 Jul; 6():29699. PubMed ID: 27412504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Checkpoint Receptor TIGIT Expressed on Tim-1
    Xiao S; Bod L; Pochet N; Kota SB; Hu D; Madi A; Kilpatrick J; Shi J; Ho A; Zhang H; Sobel R; Weiner HL; Strom TB; Quintana FJ; Joller N; Kuchroo VK
    Cell Rep; 2020 Jul; 32(2):107892. PubMed ID: 32668241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of TIGIT
    Hasan MM; Nair SS; O'Leary JG; Thompson-Snipes L; Nyarige V; Wang J; Park W; Stegall M; Heilman R; Klintmalm GB; Joo H; Oh S
    Nat Commun; 2021 Mar; 12(1):1534. PubMed ID: 33750787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
    Blumenfeld S; Staun-Ram E; Miller A
    J Autoimmun; 2016 Jun; 70():40-51. PubMed ID: 27055778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.
    Knippenberg S; Peelen E; Smolders J; Thewissen M; Menheere P; Cohen Tervaert JW; Hupperts R; Damoiseaux J
    J Neuroimmunol; 2011 Oct; 239(1-2):80-6. PubMed ID: 21940055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation.
    Xiao S; Brooks CR; Sobel RA; Kuchroo VK
    J Immunol; 2015 Feb; 194(4):1602-8. PubMed ID: 25582854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids.
    de Andrés C; Tejera-Alhambra M; Alonso B; Valor L; Teijeiro R; Ramos-Medina R; Mateos D; Faure F; Sánchez-Ramón S
    J Neuroimmunol; 2014 May; 270(1-2):37-44. PubMed ID: 24662004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIGIT expression is upregulated in T cells and causes T cell dysfunction independent of PD-1 and Tim-3 in adult B lineage acute lymphoblastic leukemia.
    Zhang X; Zhang H; Chen L; Feng Z; Gao L; Li Q
    Cell Immunol; 2019 Oct; 344():103958. PubMed ID: 31376919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIGIT Deficiency Protects Mice From DSS-Induced Colitis by Regulating IL-17A-Producing CD4
    Chen B; Ye B; Li M; Wang S; Li J; Lai Y; Yang N; Ke Z; Zhang H
    Front Immunol; 2022; 13():931761. PubMed ID: 35844584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis.
    Yu Y; Chen Z; Wang Y; Li Y; Lu J; Cui L; Yu Z; Ding Y; Guo C; Zhang X; Shi Y
    Int Immunopharmacol; 2021 Jul; 96():107722. PubMed ID: 33965878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tim-1
    Gu XL; He H; Lin L; Luo GX; Wen YF; Xiang DC; Qiu J
    APMIS; 2017 Oct; 125(10):872-879. PubMed ID: 28736945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease.
    Zhao J; Lin B; Deng H; Zhi X; Li Y; Liu Y; Bible PW; Li Q; Xu B; Wei L; Yang H; Huang D
    Curr Mol Med; 2018; 18(2):83-90. PubMed ID: 29974826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.